CD4 and pneumocystosis: Although CD4 counts play a significant role in determining risk from PcP in other cohorts (HIV, Haematology, and SOT), its role in autoimmune and inflammatory disease is less well defined, and the median CD4 count in PCP patients with this syndrome was 302/mm3 compared to 19/mm3 in HIV-positive patients [83].